Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Swiss Life Sciences Company Lonza Opens New Center in Haifa

Swiss Life Sciences Company Lonza
Lonza, a Swiss biotech company, opens their new Israeli Collaborative Innovation Center (CIC) in the Life Science Park, in Haifa. This Research & Development center features 1,000 square meters of space. CIC employs staff of 15 scientific professionals. Managed by Dr. Frida Grynspan-Gotlieb, the CIC aims to take advantage of Israel’s frontline expertise in software and cell/molecular biology and engineering in order to enhance Lonza’s capabilities.

Joint Projects with Sheba Underway

The modern R&D center will focus on cell and gene therapies, expression systems and synthetic biology, and data acquisition and analytics. The Lonza team will collaborate with local academic and health industry specialists, and they have already teamed up with the Center for Regenerative Medicine, Stem Cell, and Tissue Engineering at the Sheba Medical Center. In a joint project, Lonza and Sheba, a world-renowned leader in CAR-T therapy, will assess the Cocoon technology, which is a closed and automated cell-therapy manufacturing system that performs on the patient scale.

“Israel has established itself as a point of convergence for digital technologies, engineering and life sciences, providing new solutions for healthcare in particular. We want to expand this potential to reimagine the development and manufacturing of future medicines by working with academic institutions, teaching hospitals, and startups,” says Marc Funk, COO, and CIC Chairman.

To date, Lonza’s R&D team in Israel has signed several memorandums of understanding and talent scouting at the Weizmann Institute of Science, Tel Aviv University, and the Technion R&D Foundation.

Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More